Format

Send to

Choose Destination
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. doi: 10.1093/annonc/mdy308.

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Author information

1
Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.
2
Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
3
Department of Medicine, Royal Marsden Hospital, Surrey, UK.
4
Direttore Dipartimento di Oncologia e U.O.C. Oncologia Medica A.O., Benevento, Italy.
5
Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, Mount Sinai Liver Cancer Program, New York, USA.
6
Barcelona-Clínic Liver Cancer Group (BCLC), Unitat d'Hepatologia, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona.
7
Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
8
Oncology, Royal Free Hospital, London.
9
UCL Cancer Institute, University College London, London, UK.
10
Service d'hépatologie, Hôpital Jean Verdier, Bondy, France.
11
Klinik für Allgemein- und Viszeralchirurgie, Medizinische Fakultät der RWTH Aachen.
12
Klinik und Poliklinik für Radiologie, Ludwig-Maximilians-Universität München, Munich, Germany.
13
Liver Unit, Clinica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.
14
Institute of Pathology, University Hospital, Heidelberg, Germany.
15
Campus Gasthuisberg, UZ Leuven, Leuven, Belgium.
16
Klinik für Radiologie und Nuklearmedizin Universität Basel, Basel, Switzerland.
17
Department Oncology, Section Hematology and Palliative Care AK Altona, Asklepios Tumorzentrum Hamburg, Hamburg, Germany.
18
Faculty of Medicine, Università della Campania L. Vanvitelli Naples, Caserta, Italy.
PMID:
30285213
DOI:
10.1093/annonc/mdy308

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center